BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6234800)

  • 1. The natural history of Huntington disease: possible role of "aging genes".
    Farrer LA; Conneally PM; Yu PL
    Am J Med Genet; 1984 May; 18(1):115-23. PubMed ID: 6234800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing genetic effects in survival data by correlating martingale residuals with an application to age at onset of Huntington disease.
    Wintrebert CM; Zwinderman AH; Maat-Kievit A; Roos RA; van Houwelingen HC
    Stat Med; 2006 Sep; 25(18):3190-200. PubMed ID: 16416406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.
    Wexler NS; Lorimer J; Porter J; Gomez F; Moskowitz C; Shackell E; Marder K; Penchaszadeh G; Roberts SA; Gayán J; Brocklebank D; Cherny SS; Cardon LR; Gray J; Dlouhy SR; Wiktorski S; Hodes ME; Conneally PM; Penney JB; Gusella J; Cha JH; Irizarry M; Rosas D; Hersch S; Hollingsworth Z; MacDonald M; Young AB; Andresen JM; Housman DE; De Young MM; Bonilla E; Stillings T; Negrette A; Snodgrass SR; Martinez-Jaurrieta MD; Ramos-Arroyo MA; Bickham J; Ramos JS; Marshall F; Shoulson I; Rey GJ; Feigin A; Arnheim N; Acevedo-Cruz A; Acosta L; Alvir J; Fischbeck K; Thompson LM; Young A; Dure L; O'Brien CJ; Paulsen J; Brickman A; Krch D; Peery S; Hogarth P; Higgins DS; Landwehrmeyer B;
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3498-503. PubMed ID: 14993615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of age at onset of Huntington disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes.
    Chattopadhyay B; Baksi K; Mukhopadhyay S; Bhattacharyya NP
    Neurosci Lett; 2005 Feb; 374(2):81-6. PubMed ID: 15644269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of fertility and fitness in Huntington disease in New England.
    Mastromauro CA; Meissen GJ; Cupples LA; Kiely DK; Berkman B; Myers RH
    Am J Med Genet; 1989 Jun; 33(2):248-54. PubMed ID: 2527461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.
    Andrew SE; Goldberg YP; Kremer B; Telenius H; Theilmann J; Adam S; Starr E; Squitieri F; Lin B; Kalchman MA
    Nat Genet; 1993 Aug; 4(4):398-403. PubMed ID: 8401589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-of-onset heterogeneity in Huntington disease families.
    Pericak-Vance MA; Elston RC; Conneally PM; Dawson DV
    Am J Med Genet; 1983 Jan; 14(1):49-59. PubMed ID: 6219581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease.
    Snell RG; MacMillan JC; Cheadle JP; Fenton I; Lazarou LP; Davies P; MacDonald ME; Gusella JF; Harper PS; Shaw DJ
    Nat Genet; 1993 Aug; 4(4):393-7. PubMed ID: 8401588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length.
    Kehoe P; Krawczak M; Harper PS; Owen MJ; Jones AL
    J Med Genet; 1999 Feb; 36(2):108-11. PubMed ID: 10051007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of age at onset in siblings with familial Alzheimer disease.
    Gómez-Tortosa E; Barquero MS; Barón M; Sainz MJ; Manzano S; Payno M; Ros R; Almaraz C; Gómez-Garré P; Jiménez-Escrig A
    Arch Neurol; 2007 Dec; 64(12):1743-8. PubMed ID: 18071037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific psychiatric manifestations among preclinical Huntington disease mutation carriers.
    Marshall J; White K; Weaver M; Flury Wetherill L; Hui S; Stout JC; Johnson SA; Beristain X; Gray J; Wojcieszek J; Foroud T
    Arch Neurol; 2007 Jan; 64(1):116-21. PubMed ID: 17210818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI.
    Wolf RC; Vasic N; Schönfeldt-Lecuona C; Landwehrmeyer GB; Ecker D
    Brain; 2007 Nov; 130(Pt 11):2845-57. PubMed ID: 17855375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using survival methods to estimate age-at-onset distributions for genetic diseases with an application to Huntington disease.
    Cupples LA; Terrin NC; Myers RH; D'Agostino RB
    Genet Epidemiol; 1989; 6(2):361-71. PubMed ID: 2524419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal personality changes among presymptomatic Huntington disease gene carriers.
    Kirkwood SC; Siemers E; Viken R; Hodes ME; Conneally PM; Christian JC; Foroud T
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Sep; 15(3):192-7. PubMed ID: 12218712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early cognitive deficits in Swedish gene carriers of Huntington's disease.
    Robins Wahlin TB; Lundin A; Dear K
    Neuropsychology; 2007 Jan; 21(1):31-44. PubMed ID: 17201528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early modifications of auditory event-related potentials in carriers of the Huntington's disease gene.
    de Tommaso M; Sciruicchio V; Specchio N; Difruscolo O; Vitale C; Specchio LM; Puca F
    Acta Neurol Belg; 2003 Dec; 103(4):192-8. PubMed ID: 15008503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive scores in carriers of Huntington's disease gene compared to noncarriers.
    Foroud T; Siemers E; Kleindorfer D; Bill DJ; Hodes ME; Norton JA; Conneally PM; Christian JC
    Ann Neurol; 1995 May; 37(5):657-64. PubMed ID: 7755361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease.
    van Exel E; Eikelenboom P; Comijs H; Frölich M; Smit JH; Stek ML; Scheltens P; Eefsting JE; Westendorp RG
    Arch Gen Psychiatry; 2009 Nov; 66(11):1263-70. PubMed ID: 19884614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.
    Ribaï P; Nguyen K; Hahn-Barma V; Gourfinkel-An I; Vidailhet M; Legout A; Dodé C; Brice A; Dürr A
    Arch Neurol; 2007 Jun; 64(6):813-9. PubMed ID: 17562929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic model for age at onset in Huntington disease.
    Farrer LA; Conneally PM
    Am J Hum Genet; 1985 Mar; 37(2):350-7. PubMed ID: 3157315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.